Literature DB >> 17471014

Autophagy in a mouse model of distal myopathy with rimmed vacuoles or hereditary inclusion body myopathy.

May Christine V Malicdan1, Satoru Noguchi, Ichizo Nishino.   

Abstract

Distal myopathy with rimmed vacuoles (DMRV) or hereditary inclusion body myopathy (hIBM) is an autosomal recessive disorder clinically characterized by weakness that initially involves the distal muscles, although other muscles can be affected as well. Pathological hallmarks include the presence of rimmed vacuoles (RVs) and intracellular Congo red-positive depositions in vacuolated or nonvacuolated fibers. Mutations in the UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase (GNE) gene, which encodes the rate-limiting enzyme in sialic acid biosynthesis, are causative of DMRV/hIBM. Recently, we have generated a mouse model (Gne(-/-)hGNEV572L-Tg) for this disease, and have shown that these mice exhibit hyposialylation and intracellular amyloid deposition before the characteristic RVs are detected, indicating that autophagy is a downstream phenomenon to hyposialylation and amyloid deposition in DMRV/hIBM.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17471014     DOI: 10.4161/auto.4270

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  27 in total

Review 1.  Animal models of inflammatory myopathy.

Authors:  Dana P Ascherman
Journal:  Curr Rheumatol Rep       Date:  2012-06       Impact factor: 4.592

2.  In vitro studies in VCP-associated multisystem proteinopathy suggest altered mitochondrial bioenergetics.

Authors:  Angèle Nalbandian; Katrina J Llewellyn; Arianna Gomez; Naomi Walker; Hailing Su; Andrew Dunnigan; Marilyn Chwa; Jouni Vesa; M C Kenney; Virginia E Kimonis
Journal:  Mitochondrion       Date:  2015-02-25       Impact factor: 4.160

3.  Diagnosis and treatment of inflammatory myopathy: issues and management.

Authors:  Christine Castro; Mark Gourley
Journal:  Ther Adv Musculoskelet Dis       Date:  2012-04       Impact factor: 5.346

4.  Sialic acid deficiency is associated with oxidative stress leading to muscle atrophy and weakness in GNE myopathy.

Authors:  Anna Cho; May Christine; V Malicdan; Miho Miyakawa; Ikuya Nonaka; Ichizo Nishino; Satoru Noguchi
Journal:  Hum Mol Genet       Date:  2017-08-15       Impact factor: 6.150

5.  Novel compound heterozygous variants in the GFPT1 gene leading to rare limb-girdle congenital myasthenic syndrome with rimmed vacuoles.

Authors:  Yanyan Ma; Ting Xiong; Guohua Lei; Jiaqi Ding; Rui Yang; Zunbo Li; Jun Guo; Dingguo Shen
Journal:  Neurol Sci       Date:  2021-01-13       Impact factor: 3.307

6.  Autophagy-Lysosome Pathway in Renal Tubular Epithelial Cells Is Disrupted by Advanced Glycation End Products in Diabetic Nephropathy.

Authors:  Wei Jing Liu; Ting Ting Shen; Rui Hong Chen; Hong-Luan Wu; Yan Jin Wang; Jian Kun Deng; Qiu Hua Chen; Qingjun Pan; Chang-mei Huang Fu; Jing-li Tao; Dong Liang; Hua-feng Liu
Journal:  J Biol Chem       Date:  2015-06-22       Impact factor: 5.157

7.  Variable phenotypes of knockin mice carrying the M712T Gne mutation.

Authors:  Ilan Sela; Lena Yakovlev; Michal Becker Cohen; Moran Elbaz; Nurit Yanay; Uri Ben Shlomo; Hagit Yotvat; Yakov Fellig; Zohar Argov; Stella Mitrani-Rosenbaum
Journal:  Neuromolecular Med       Date:  2012-12-13       Impact factor: 3.843

8.  A preclinical trial of sialic acid metabolites on distal myopathy with rimmed vacuoles/hereditary inclusion body myopathy, a sugar-deficient myopathy: a review.

Authors:  May Christine V Malicdan; Satoru Noguchi; Ichizo Nishino
Journal:  Ther Adv Neurol Disord       Date:  2010-03       Impact factor: 6.570

9.  Prophylactic treatment with sialic acid metabolites precludes the development of the myopathic phenotype in the DMRV-hIBM mouse model.

Authors:  May Christine V Malicdan; Satoru Noguchi; Yukiko K Hayashi; Ikuya Nonaka; Ichizo Nishino
Journal:  Nat Med       Date:  2009-06       Impact factor: 53.440

10.  Ganglioside GM3 levels are altered in a mouse model of HIBM: GM3 as a cellular marker of the disease.

Authors:  Thomas Paccalet; Zoé Coulombe; Jacques P Tremblay
Journal:  PLoS One       Date:  2010-04-07       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.